-
CSR Summary Not Available
-
NCT Number Not Available
-
Primary Citation
-
Data Specification Not Available
You are not logged in.
Please login to continue selecting trials.
Trial Information
Generic NameN/AProduct NameN/ATherapeutic AreaGene ExpressionEnrollment196% Female61%% WhiteN/A
Product ClassGene ExpressionSponsor Protocol NumberN/AData PartnerJohnson & JohnsonCondition StudiedUni-polar DepressionMean/Median Age (Years)38
Supporting Documentation
- Collected Datasets Available
- Data Definition Specification Available
Additional Information
This study was designed primarily for biomarker discovery. Microarray data were available for analysis (after quality control) from whole-blood samples stored for less than 1 year on a sample comprising 94 patients with MDD and 100 healthy control subjects.
The complementary GlaxoSmithKline HiTDiP data set included in this study has been made publicly available on the Gene Expression Omnibus website (https://www.ncbi.nlm.nih.gov/geo) as GSE98793.